Behavioral Health Business Valuations in 2026: What Owners Should Expect
A behavioral health business in 2026 is worth roughly 3.0x to 8.0x EBITDA in the middle of the market, and scaled, accredited, multi-site platforms are closing between 10.0x and 14.0x. Solo counseling practices with owner-dependent revenue sit lower, in the 1.9x to 3.1x SDE range. Where your business lands inside that spread has less to do with the sub-vertical and more to do with payer mix, clinician retention, and how much of the revenue walks out the door when you do.
I have sold enough of these to tell you the number in your head is usually anchored to revenue. Buyers do not buy revenue. They buy durable, transferable cash flow. That distinction is the whole ballgame.
At a Glance
- Typical range: 3.0x-8.0x EBITDA (mid-market)
- Scaled platforms: 10.0x-14.0x EBITDA
- Solo practices: 1.9x-3.1x SDE
- Deal timeline: 6-12 months
- 2025 deal volume: 104 transactions, up 42% year over year
Who this is for
This is for the owner of an outpatient therapy group, a psychiatric practice, an autism/ABA provider, a substance use disorder program, or an intensive outpatient facility who wants a straight answer about value before they talk to a single buyer. If you are three to five years from an exit, this is also for you, because the moves that lift a multiple take that long to season.
How are behavioral health businesses valued?
Nearly every deal I run comes down to adjusted EBITDA times a multiple. First we normalize earnings: add back your above-market owner compensation, one-time expenses, and any personal costs running through the business, then subtract a fair-market salary for whoever replaces your clinical and administrative role. That normalized EBITDA is the number a buyer underwrites. Smaller, owner-operated practices get valued on Seller's Discretionary Earnings instead, which keeps one owner's salary in the cash flow. Knowing which lens applies to you changes the headline number materially, so I settle that first.
What are current behavioral health multiples?
In 2026, expect 3.0x-8.0x EBITDA for a well-run mid-market group, with the top of that band reserved for practices with diversified payers, credentialed W-2 clinicians, and clean compliance. Accredited, multi-state platforms with real management infrastructure are trading at 10.0x-14.0x because they are the roll-up targets buyers pay premiums to anchor. A size premium of roughly 0.5x-1.5x kicks in as you cross meaningful EBITDA thresholds, simply because larger platforms carry lower key-person risk and a bigger base for a buyer to build on.
Who is buying behavioral health businesses?
The buyer pool is deep and getting deeper. Private equity poured into physician and behavioral practices through 2025, and behavioral health was one of the most active verticals. Named acquirers and PE-backed platforms include LifeStance Health, Geode Health (backed by KKR), Mindpath Health, Refresh Mental Health (part of Optum), Transformations Care Network, Thriveworks, and ARC Health. Strategic health systems and payers are in the mix too. When you have multiple platform buyers competing for the same clean book, that competition is where premium multiples actually come from - and it is why I run a controlled process rather than a one-off conversation.
What makes a behavioral health business worth more?
The value drivers are consistent: a payer mix that is not overexposed to a single contract, a roster of employed clinicians under non-competes rather than 1099 contractors who can leave with their caseload, documented outcomes, and a compliance and billing function that survives diligence. Recurring, credentialed revenue with 90-day-plus visibility trades at a premium. Practices where the owner is still the top biller and the face of every referral relationship trade at a discount, because the buyer is underwriting the risk that the cash flow leaves with you.
What hurts behavioral health valuations?
The recurring value killers are owner dependence, payer concentration, and messy documentation. If one contract or referral source is 30% of revenue, expect a discount or an earnout tied to keeping it. Heavy reliance on 1099 clinicians, sloppy medical records, unresolved compliance exposure, or billing that cannot be reconciled to bank deposits all knock the multiple down or blow up diligence entirely. Deferred maintenance on your management team is just as damaging as any of it - if there is no one but you running the clinical and business side, buyers price that risk in hard.
How long does it take to sell?
Plan on 6 to 12 months from the day we take the business to market to a funded close. Preparing financials, normalizing earnings, and assembling a clean diligence package is 30 to 60 days of that. A competitive buyer process runs another few months, and diligence plus definitive documents on a healthcare deal - with licensing, payer credentialing, and regulatory review - is where timelines stretch. The practices that close fast are the ones that did the cleanup work before going to market.
I sold a two-clinician outpatient group last year where the owner was convinced she had a 6x business. She did not - she had a 3x business with a 6x business hiding inside it. We spent nine months moving her top referrals onto documented, institutional relationships and converting her contractors to employed clinicians. When we finally went to market, three PE-backed platforms bid and the winning number was almost double where she started. Nothing about the therapy changed. What changed was how transferable the cash flow looked to a buyer.
If you want to see roughly where you stand before doing any of that work, my behavioral health valuation resources walk through the drivers in more detail, and my breakdown of who is actively buying behavioral health businesses in 2026 shows which platforms are paying the top multiples right now.
Find Out What Your Behavioral Health Business Is Worth
Start with my free valuation calculator to get a realistic range in a few minutes. When you are ready, I will walk you through a confidential, no-obligation consultation to pressure-test that number against real buyer demand.
